In general, reported 5-year survival rates are 85% to 90% for stage IB, about 75% for stage IIA, 60% to 65% for IIB, 25% to 50% for stage IIIB, and 10% or less for stage IV. For bulky lesions, a combination of preoperative irradiation and hysterectomy has been tried; however, in some studies the results are no better than those noted with higher doses of irradiation alone.